IPO Guru

IPO Listed — 30 Jul 2026

Listing Price: ₹700 (+44.33% vs ₹485)

View GMP History →
Indo-MIM

Indo-MIM IPO Review

Indo-MIM IPO has been reviewed by 10 analysts, and the overall consensus is Strong Apply — carrying a score of 93. Out of the 10 analysts who have covered this IPO, 8 recommend subscribing while 2 advise caution or avoidance — reflecting a mixed view from the analyst community.

The issue is priced in the band of ₹461-485 per share , with a minimum application size of 30 shares (minimum investment of approximately ₹14,550 at the upper band) . Subscription ran from 23 Jul 2026 to 27 Jul 2026. As of now, the grey market premium (GMP) for Indo-MIM IPO is quoting at ₹184 (37.9%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.

General Review

Indo-MIM is the world's largest maker of precision metal parts using MIM technology, with a diversified business across automotive, defence, medical, consumer and aerospace. FY26 revenue grew about 26% with healthy margins and ROE near 21%. At about 45 times FY26 earnings it looks fully priced, but 8 of 10 analysts rate it Subscribe.

Listing Gains

The IPO is seeing strong demand, with grey market premium around Rs 165, about 34% over the Rs 485 upper price. Given the company's global leadership, healthy financials and positive analyst mood, a good listing gain looks likely. But GMP changes fast, so treat listing gains as a bonus, not a guarantee.

Short Term Strategy

For short-term traders, the main attraction is the listing-day gain from strong demand and a healthy grey market premium. If you get allotment, booking part or full profit on listing day looks sensible. The valuation is rich at about 45 times earnings, so chasing the stock at high prices after listing is risky.

Long Term Strategy

For long-term investors, Indo-MIM is a quality, market-leading business gaining from the China+1 and Make in India trend, with sticky global customers and growing capacity. Most analysts suggest holding for the medium-to-long term. The premium valuation may limit quick gains, so add on dips and stay invested for multi-year growth.

Disclaimer: This review is an AI summary derived from the reviews of all analysts.

Analyst Sentiment

Analytical Score

How it's calculated?
Strong Apply
93 / 100

Recommend Subscribe

Based on 10 analyst reviews

8 / 10

Higher consensus indicates broader analyst agreement.

Analyst Review

Latest IPO Reviews

Frequently Asked Questions

Should I apply for Indo-MIM IPO?

Based on analyst coverage tracked on this page, the overall verdict for Indo-MIM IPO is Strong Apply. Out of 10 analysts who have reviewed this IPO, 8 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.

What does the score of 93 mean for Indo-MIM IPO?

The score of 93 is an aggregate of all analyst ratings tracked for Indo-MIM IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.

What was the actual listing price of Indo-MIM IPO?

Indo-MIM IPO listed on July 30, 2026 at ₹700 , against the issue price of ₹485 — a gain of +44.33% (₹215 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Indo-MIM IPO?

Indo-MIM IPO was priced at ₹461-485 per share. The minimum lot size is 30 shares, making the minimum investment approximately ₹14,550 at the upper end of the price band. Subscription ran from 23 Jul 2026 to 27 Jul 2026.

Explore Indo-MIM IPO Further

Track every stage of this IPO:

Discussion 0

💡
Commenting as
Markdown supported: **bold**, _italics_

No comments yet

Be the first to share your thoughts!

Advertisement
Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.